Adverse Event Reports

Pharmacovigilance
Your Safety is Our Priority

At Varifarma, we are committed not only to developing high-quality medicines but also to ensuring the safety and well-being of those who trust in our products.

What is
Pharmacovigilance?

Pharmacovigilance, also known as Drug Safety, involves the ongoing monitoring and assessment of a medication's safety profile after it has been authorized and made available to the public. The primary objective is to identify, assess, understand, and prevent any adverse effects or issues associated with the use of pharmaceuticals to safeguard the health of both patients and the community. Pharmacovigilance activities promote the rational and safe use of medicines for the benefit of global health.

Our Commitment to Safety

Patient safety is our top priority. Our team of Pharmacovigilance experts works diligently to collect and analyze data regarding potential adverse effects of our products. This information is gathered from various sources, including healthcare professionals (HCPs), patients, and regulatory reports.

Reporting Suspected Adverse Effects

Pharmacovigilance is a shared responsibility among physicians, the pharmaceutical industry, local health authorities, and patients. If you have experienced any unexpected side effects while using one of our products, we encourage you to report them. Your contribution is essential to ensuring the ongoing safety and quality of our treatments. You can report adverse events through our contact channels listed below.

Transparency and Access to Information

We believe in transparency and open communication. Through our safety reports and continuous website updates, we share the latest safety information. Additionally, we collaborate closely with regulatory authorities to ensure strict compliance with international pharmacovigilance standards.

Patient safety is fundamental to our mission, and we work tirelessly to uphold the highest quality and safety standards for our products. Together, we are building a healthier and safer future.

Report an Event

In case of suspected adverse events (AEs) related to any of our medicines, please report them through the channels provided by our subsidiaries in Latin America. Alternatively, you may also report by completing the form below.

Argentina

Perú

Chile

Ecuador

Uruguay